Skip to contentParker Geoffrey M. — ChemoCentryx, Inc. insider: 246 transactions · InsiderLensParker Geoffrey M.
- CHIEF FINANCIAL OFFICER at Allogene Therapeutics, Inc. · on record since Oct 17, 2023
- Director at GENOPTIX INC · on record since Jun 3, 2010
- Director at ChemoCentryx, Inc. · on record since Feb 13, 2012
- Director at PERRIGO CO · on record since May 15, 2026
- Executive Vice President & CFO at Anacor Pharmaceuticals Inc · on record since May 30, 2014
- Director at SUNESIS PHARMACEUTICALS INC · on record since May 27, 2016
- Director at GENOMIC HEALTH INC · on record since Jun 23, 2016
- COO, CFO and EVP at Tricida, Inc. · on record since Jun 27, 2018
- Director at Mountain Crest Acquisition Corp II · on record since Dec 16, 2021
Insider trading activity of Parker Geoffrey M.
- Transactions on record
- 246
- since Jun 3, 2010
- Open-market buys
- 75
- $9.1M
- Open-market sells
- 13
- $3.3M
- Companies traded
- 9
- last filing Jun 16, 2026
Figures computed from official regulatory filings — methodology.
Companies where Parker Geoffrey M. has traded
- PERRIGO CO63 tx · $5.1M · Jun 16, 2026
- Allogene Therapeutics, Inc.15 tx · $1.2M · Feb 4, 2026
- Mountain Crest Acquisition Corp II10 tx · $918.9K · Dec 20, 2023
- ChemoCentryx, Inc.67 tx · $4.2M · Oct 24, 2022
- Tricida, Inc.26 tx · $6.1M · Mar 2, 2022
- GENOMIC HEALTH INC10 tx · Nov 14, 2019
- SUNESIS PHARMACEUTICALS INC9 tx · $58.3K · Jun 2, 2017
- Anacor Pharmaceuticals Inc41 tx · $2.5M · Mar 23, 2015
- GENOPTIX INC5 tx · $18.3K · Mar 1, 2011
Track record of Parker Geoffrey M.
Statistical track record
Free- Open-market buys
- 75
- Last buy
- Nov 12, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Parker Geoffrey M.
Co-insiders of Parker Geoffrey M.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
667, L.P.GENOMIC HEALTH INC
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 16, 2026 | AwardD | 844 | — | — | SEC |
| Jun 16, 2026 | ExerciseD | -976 | — | — | SEC |
| Jun 16, 2026 | Other | -469 | 10.99 USD | $5.2K | SEC |
| Jun 16, 2026 | Exercise | 976 | 10.99 USD | $10.7K | SEC |
| May 15, 2026 | AwardD | 16,681 | — | — | SEC |
| May 15, 2026 | Exercise | 7,305 | 10.84 USD | $79.2K | SEC |
| May 15, 2026 | ExerciseD | -7,305 | — | — | SEC |
| May 15, 2026 | Other | -3,507 | 10.84 USD | $38K | SEC |
| Mar 17, 2026 | AwardD | 3,024 | — | — | SEC |
| Feb 4, 2026 | AwardD | 539,072 | 0.00 USD | $0 | SEC |
| Feb 4, 2026 | AwardD | 152,480 | 0.00 USD | $0 | SEC |
| Feb 4, 2026 | Sell | -24,001 | 1.76 USD | $42.2K | SEC |
| Dec 16, 2025 | AwardD | 2,140 | — | — | SEC |
| Nov 14, 2025 | Buy | 7,500 | 14.18 USD | $106.4K | SEC |
| Oct 23, 2025 | Sell | -36,744 | 1.26 USD | $46.3K | SEC |
| Sep 16, 2025 | AwardD | 1,263 | — | — | SEC |
| Aug 20, 2025 | Buy | 4,375 | 22.97 USD | $100.5K | SEC |
| Aug 19, 2025 | Buy | 4,375 | 22.97 USD | $100.5K | SEC |
| Jun 17, 2025 | AwardD | 976 | — | — | SEC |
| May 16, 2025 | Exercise | 9,904 | 26.01 USD | $257.6K | SEC |
| May 16, 2025 | AwardD | 7,305 | — | — | SEC |
| May 16, 2025 | Other | -4,754 | 26.01 USD | $123.7K | SEC |
| May 16, 2025 | ExerciseD | -9,904 | — | — | SEC |
| May 14, 2025 | Buy | 3,500 | 27.10 USD | $94.9K | SEC |
| Feb 5, 2025 | Sell | -4,361 | 1.73 USD | $7.5K | SEC |